Proof-of-concept study to evaluate the safety and efficacy of saroglitazar in patients with primary biliary cholangitis-Reference-Cited by-同舟云学术

Proof-of-concept study to evaluate the safety and efficacy of saroglitazar in patients with primary biliary cholangitis

Published:2022-01 Issue:1 Volume:76 Page:75-85
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Vuppalanchi Raj^ORCID,Caldwell Stephen H.,Pyrsopoulos Nikolaos^ORCID,deLemos Andrew S.^ORCID,Rossi Simona,Levy Cynthia^ORCID,Goldberg David S.,Mena Edward A.,Sheikh Aasim^ORCID,Ravinuthala Ravi,Shaikh Farheen,Bainbridge James D.,Parmar Deven V.^ORCID,Chalasani Naga P.

Publisher

Elsevier BV

Subject

Hepatology

Reference67 articles.

1. Diagnosis and management of primary biliary cholangitis;Younossi;Am J Gastroenterol,2019

2. Incidence, prevalence, and outcome of primary biliary cholangitis in a nationwide Swedish population-based cohort;Marschall;Sci Rep,2019

3. Primary biliary cholangitis: 2018 practice guidance from the American association for the study of liver diseases;Lindor;Hepatology,2019

4. EASL Clinical Practice Guidelines: the diagnosis and management of patients with primary biliary cholangitis;J Hepatol,2017

5. Primary biliary cholangitis: pathogenesis and therapeutic opportunities;Gulamhusein;Nat Rev Gastroenterol Hepatol,2020

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel Dual PPAR δ/γ Partial Agonist Induces Hepatic Lipid Accumulation through Direct Binding and Inhibition of AKT1 Phosphorylation, Mediating CD36 Upregulation;Chemical Research in Toxicology;2024-09-05

2. Primary biliary cholangitis;The Lancet;2024-09

3. Efficacy and safety of peroxisome proliferator-activated receptor agonists for the treatment of primary biliary cholangitis: a meta-analysis of randomized controlled trials;Frontiers in Pharmacology;2024-07-22

4. Biliary fibrosis is an important but neglected pathological feature in hepatobiliary disorders: from molecular mechanisms to clinical implications;Medical Review;2024-07-01

5. Exploring the potential of drug repurposing for liver diseases: A comprehensive study;Life Sciences;2024-06